1Kleinman HK, McGarvey ML, Liotta LA, et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma[J]. Biochemistry, 1982, 21(24): 6188-6193.
2Terranova VP, Hujanen ES, Loeb DM, et al. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells[J]. Proc Natl Acad Sci USA, 1986, 83(2): 465-469.
3Repesh LA. A new in vitro assay for quantitating tumor cell invasion[J]. Invasion Metastasis, 1989, 9(3): 192-208.
4Ahonen M, Baker AH, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells[J]. Cancer Res, 1998, 58(11): 2310-2315.
5Schroeder M, Mass MJ. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene[J]. Biochem Biophys Res Commun, 1997, 235(2): 403-406.
6Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma[J]. Proc Natl Acad Sci USA, 1994, 91(21): 9700-9704.
7Baylin S. DNA methylation and epigenetic mechanisms of carcinogenesis[J]. Dev Biol (Basel), 2001, 106: 85-87; discussion: 143-146.
8Jones PA. DNA methylation errors and cancer[J]. Cancer Res, 1996, 56(11): 2463-2467.
9Bachman KE, Herman JG, Corn PG, et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers[J]. Cancer Res, 1999, 59(4): 798-802.
10Virmani AK, Rathi A, Sathyanarayana UG, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas[J]. Clin Cancer Res, 2001, 7(7): 1998-2004.
